Top Markets
Coin of the day
TaiwanJ Pharmaceuticals Co., Ltd. TaiwanJ Pharmaceuticals Co., Ltd.

TaiwanJ Pharmaceuticals Co., Ltd.

6549
Rangering i aksjer #30200
TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm... TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm dedicated to the research, development, and commercialization of small molecule therapeutics. Initially, its focus within Taiwan has been on tackling chronic organ inflammation stemming from metabolic, autoimmune, or infectious causes. The company's growing pipeline also features specific compounds like JKB-122 and JKB-121, alongside a collection of innovative chemical entities. These new drugs are being developed to address persistent liver conditions and allergic respiratory ailments, such as asthma. TaiwanJ's comprehensive product portfolio is engineered to combat a wide array of diseases, encompassing hepatic inflammation and fibrosis, non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), various autoimmune disorders, asthma, and atopic dermatitis (eczema). Established in 2011, the company's operations are headquartered in Zhubei, Taiwan.
Aksjekurs
$0.22227521
Markedsverdi
$17.81M
Endring (1 dag)
0.00%
Endring (1 år)
-14.81%
Land
TW
Handel TaiwanJ Pharmaceuticals Co., Ltd. (6549)

Kategori

Historikk for aksjesplitt for TaiwanJ Pharmaceuticals Co., Ltd. (6549)
Aksjen TaiwanJ Pharmaceuticals Co., Ltd. (symbol: 6549) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 19, 2026.
Én 6549-aksje kjøpt før Aug 19, 2026 tilsvarer i dag 0 6549-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR